Replicate real‐time PCR testing of DNA in maternal plasma increases the sensitivity of non‐invasive fetal sex determination

Abstract

Amplification of free fetal DNA in maternal plasma is a valid and rapid technique for predicting fetal sex in first- and second-trimester pregnancies and could allow the restriction of invasive sampling procedures to male fetuses at risk of X-linked disorders.